摘要
目的:分析复方余甘子含片对人口咽部甲型链球菌(甲链)及唾液SIgA的影响,初步探讨该含片的作用机理。方法:筛选健康人群及慢性咽炎人群含服复方余甘子含片,采集含片前后咽拭子及唾液,咽拭子用于检测甲链,ELISA检测唾液中的SIgA含量。结果:含服复方余甘子含片2周后,慢性咽炎人群优势菌甲链升高(P=0.004<0.05);健康人群唾液中SIgA含量升高(P=0.012<0.05);且慢性咽炎的甲链升高与SIgA含量呈正相关关系(R=0.48,P=0.007<0.05)。结论:复方余甘子含片不论对慢性咽炎人群还是对健康人群,均有一定的防治上呼吸道感染的作用。
Objective: To analyze the compound emblica Streptococcus throat lozenges on the population(a chain) and the impact of SIgA in saliva,a preliminary study the mechanism of the tablet.Methods: Screening healthy people and people with chronic pharyngitis emblica compound sublingual tablets,throat swab and saliva collected before and after tablets,throat swabs for the detection of a chain,ELISA detection of SIgA content in saliva.Results: The sublingual tablet Compound emblica after 2 weeks of chronic pharyngitis among a chain of dominant bacteria increased(P=0.0040.05);SIgA content in saliva of healthy people increased(P=0.0120.05);and chronic pharyngeal A chain of increased inflammation and a positive correlation between SIgA levels(R=0.48,P=0.0070.05).Conclusion: Compound emblica tablet or whether people with chronic pharyngitis in healthy people,have some role in prevention and treatment of upper respiratory tract infection.
出处
《中医药导报》
2010年第12期85-87,共3页
Guiding Journal of Traditional Chinese Medicine and Pharmacy
基金
云南省教育厅科学研究基金一般项目(08Y0215)